These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39081128)

  • 1. Texture-based morphometry in relation to apolipoprotein ε4 genotype, ageing and sex in a midlife population.
    Dounavi ME; Mak E; Operto G; Muniz-Terrera G; Bridgeman K; Koychev I; Malhotra P; Naci L; Lawlor B; Su L; Falcon C; Ritchie K; Ritchie CW; Gispert JD; O'Brien JT
    Hum Brain Mapp; 2024 Aug; 45(11):e26798. PubMed ID: 39081128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia.
    Vipin A; Kumar D; Soo SA; Zailan FZ; Leow YJ; Koh CL; Ng ASL; Ng KP; Kandiah N
    Alzheimers Res Ther; 2023 Jun; 15(1):103. PubMed ID: 37270543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.
    Sampedro F; Vilaplana E; de Leon MJ; Alcolea D; Pegueroles J; Montal V; Carmona-Iragui M; Sala I; Sánchez-Saudinos MB; Antón-Aguirre S; Morenas-Rodríguez E; Camacho V; Falcón C; Pavía J; Ros D; Clarimón J; Blesa R; Lleó A; Fortea J;
    Oncotarget; 2015 Sep; 6(29):26663-74. PubMed ID: 26397226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study.
    Dounavi ME; Newton C; Jenkins N; Mak E; Low A; Muniz-Terrera G; Williams GB; Lawlor B; Naci L; Malhotra P; Mackay CE; Koychev I; Ritchie K; Ritchie CW; Su L; O'Brien JT
    J Neurol; 2022 Aug; 269(8):4299-4309. PubMed ID: 35279756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's disease.
    Adluru N; Destiche DJ; Lu SY; Doran ST; Birdsill AC; Melah KE; Okonkwo OC; Alexander AL; Dowling NM; Johnson SC; Sager MA; Bendlin BB
    Neuroimage Clin; 2014; 4():730-42. PubMed ID: 24936424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
    Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
    Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of apolipoprotein E4 genotype on cerebro-cerebellar connectivity, brain atrophy, and cognition in patients with Alzheimer's disease.
    de Dieu Uwisengeyimana J; Wang Y; Nguchu BA; Wang X; Qiu B
    J Neurol Sci; 2022 Nov; 442():120435. PubMed ID: 36201963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sex and APOE ε4 genotype on brain mitochondrial high-energy phosphates in midlife individuals at risk for Alzheimer's disease: A 31Phosphorus MR spectroscopy study.
    Jett S; Dyke JP; Boneu Yepez C; Zarate C; Carlton C; Schelbaum E; Jang G; Pahlajani S; Williams S; Diaz Brinton R; Mosconi L
    PLoS One; 2023; 18(2):e0281302. PubMed ID: 36787293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affect of APOE on information processing speed in non-demented elderly population: a preliminary structural MRI study.
    Luo X; Jiaerken Y; Yu X; Huang P; Qiu T; Jia Y; Sun J; Zhou J; Zhang M;
    Brain Imaging Behav; 2017 Aug; 11(4):977-985. PubMed ID: 27444731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal MRI of grey matter, white matter, and functional connectivity in cognitively healthy mutation carriers at risk for frontotemporal dementia and Alzheimer's disease.
    Feis RA; Bouts MJRJ; Dopper EGP; Filippini N; Heise V; Trachtenberg AJ; van Swieten JC; van Buchem MA; van der Grond J; Mackay CE; Rombouts SARB
    BMC Neurol; 2019 Dec; 19(1):343. PubMed ID: 31881858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults.
    Ten Kate M; Sanz-Arigita EJ; Tijms BM; Wink AM; Clerigue M; Garcia-Sebastian M; Izagirre A; Ecay-Torres M; Estanga A; Villanua J; Vrenken H; Visser PJ; Martinez-Lage P; Barkhof F
    Neurobiol Aging; 2016 Feb; 38():14-20. PubMed ID: 26827639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adults.
    Grau-Rivera O; Operto G; Falcón C; Sánchez-Benavides G; Cacciaglia R; Brugulat-Serrat A; Gramunt N; Salvadó G; Suárez-Calvet M; Minguillon C; Iranzo Á; Gispert JD; Molinuevo JL;
    Alzheimers Res Ther; 2020 Jan; 12(1):4. PubMed ID: 31907066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.
    Chételat G; Fouquet M
    Rev Neurol (Paris); 2013 Oct; 169(10):729-36. PubMed ID: 24016463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET.
    Tato-Fernández C; Ekblad LL; Pietilä E; Saunavaara V; Helin S; Parkkola R; Zetterberg H; Blennow K; Rinne JO; Snellman A
    Neurobiol Dis; 2024 Mar; 192():106439. PubMed ID: 38365046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.
    Alexander GE; Bergfield KL; Chen K; Reiman EM; Hanson KD; Lin L; Bandy D; Caselli RJ; Moeller JR
    Neurobiol Aging; 2012 Dec; 33(12):2723-32. PubMed ID: 22405043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of APOE2 and APOE4 on brain microstructure in older adults: modification by age, sex, and cognitive status.
    Reas ET; Triebswetter C; Banks SJ; McEvoy LK
    Alzheimers Res Ther; 2024 Jan; 16(1):7. PubMed ID: 38212861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
    Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
    Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.
    Agosta F; Vossel KA; Miller BL; Migliaccio R; Bonasera SJ; Filippi M; Boxer AL; Karydas A; Possin KL; Gorno-Tempini ML
    Proc Natl Acad Sci U S A; 2009 Feb; 106(6):2018-22. PubMed ID: 19164761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein e4 affects topographical changes in hippocampal and cortical atrophy in Alzheimer's disease dementia: a five-year longitudinal study.
    Kim YJ; Cho H; Kim YJ; Ki CS; Chung SJ; Ye BS; Kim HJ; Kim JH; Kim ST; Lee KH; Jeon S; Lee JM; Chin J; Kim JH; Na DL; Seong JK; Seo SW
    J Alzheimers Dis; 2015; 44(4):1075-85. PubMed ID: 25391384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.